Current diagnosis and therapy of osteoporosis on the basis of "european guidance 2008";Aktuelle Diagnostik und Therapie der Osteoporose auf der Basis der .,European Guidance 2008"

Orthopade

Volumn 38, Issue 4, 2009, Pages 365-380

  Bartl, R ^a   Gradinger, R ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diagnosis; Drugs; European guidance; Osteoporosis; Risk factors

Indexed keywords

ALENDRONIC ACID; ALENDRONIC ACID PLUS COLECALCIFEROL; CLODRONIC ACID; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ZOLEDRONIC ACID;

BONE DENSITY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; DISABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; THERAPEUTIC ERROR;

EID: 64649100958     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-008-1404-4     Document Type: Review

References (75)

1. Bartl 2002 Internist 43 1529
2. Bartl R (2007) Leitliniengerechtes Management der Osteoporose: Rationell - kostensparend - effektiv Dtsch Med Wochenschr 132:995-999
3. Bartl R (2008) Osteoporose - Prävention, Diagnostik, Therapie, 3. Aufl. Thieme, Stuttgart
4. Bartl 2003 Unfallchirurg 106 526
5. Bartl R, Frisch B (2004) Osteoporosis: diagnosis, prevention, therapy. A practical guide for all physicians - from pediadrics to geriatrics. Springer, Berlin Heidelberg New York
6. Bartl R, Frisch B, von Tresckow E, Bartl C (2007) Bisphosphonates in medical practice. Springer, Berlin Heidelberg New York
7. Bartl 2005 Osteoporos Int 16 195
8. Bartl 2007 Gynäkologe 40 913
9. Bischoff-Ferrari 1999 JAMA 28 1999
10. Black 2006 JAMA 296 2927
11. Black 2005 N Engl J Med 353 555
12. Black 2007 N Engl J Med 356 1809
13. Black 2003 N Engl J Med 249 1207
14. Blake 2007 J Clin Densitom 10 102
15. Blake 2003 J Bone Miner Res 18 1955
16. Bonaiuti 2002 Cochrane Database Syst Rev 3 CD000333
17. Boonen 2005 Osteoporos Int 16 239
18. Bruyère 2007 J Clin Endocrinol Metab 92 3076
19. Burge 2007 J Bone Miner Res 22 465
20. Caro 2004 Osteoporos Int 15 1003
21. Carr 2006 Osteoporos Int 17 1638
22. Chen 2006 J Bone Miner Res 21 1785
23. Consensus 1993 Am J Med 94 646
24. Cooper 1993 Am J Epidemiol 137 1001
25. Cranney 2002 Endocr Rev 23 570
26. Cranney 2002 Endocr Rev 23 540
27. Cummings 1999 JAMA 281 2189
28. Cummings 2006 Am J Med 112 281
29. DaFonseca 2006 Orthopäde 35 1101
30. Delmas 2006 Arthritis Rheum 54 1838
31. Delmas 2005 Osteoporos Int 16 1
32. Engelke 2006 Osteoporos Int 17 1283
33. Grady 2003 N Engl J Med 348 1835
34. Harada 2003 Nature 423 349
35. Harris 1999 JAMA 282 1344
36. Häussler 2006 Dtsch Ärztebl 39 B2199
37. Johnell 2006 Osteoporos Int 17 1726
38. Johnell 2002 Osteoporos Int 13 523
39. Kanis 2008 Osteoporos Int 19 399
40. Kanis 2008 Bone 42 4
41. Kanis 2000 Osteoporos Int 11 192
42. Kanis 2005 Osteoporos Int 16 220
43. Kanis 2005 Osteoporos Int 16 6
44. Kanis 2003 Bone 32 468
45. Lewiecki 2004 J Clin Endocrinol Metab 89 3651
46. Looker 1998 Osteoporos Int 8 468
47. Lyles 2007 N Engl J Med 357 1799
48. [tmp] McClung 2001 N Engl J Med 344 333
49. Miller 1999 J Clin Endocrinol Metab 84 1867
50. Murray CJL, Lopez AP (1996) Global and regional descriptive epidemiology of disability. Incidence, prevalence, health expectancies and years lived with disability. In: Murray CJL, Lopez AD (eds) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge/MA
51. Myers 1996 Bone 18 87S
52. Neer 2001 N Engl J Med 344 1434
53. Oliver 2007 BMJ 334 82
54. Pazianas 2008 Osteoporos Int 19 773
55. Rabenda 2005 Curr Rheumatol Rev 1 49
56. Rabenda 2008 Osteoporos Int 19 811
57. Raisz 2005 N Engl J Med 353 164
58. Reginster 2006 Future Rheumatol 1 37
59. Reginster 2005 J Clin Endocrinol Metab 90 2816
60. Richy 2004 Osteoporos Int 15 301
61. Richy 2005 Calcif Tissue Int 76 176
62. Rizzoli 2004 J Bone Miner Res 19 527
63. Rosen 2005 N Engl J Med 353 595
64. Russell 2008 Osteoporos Int 19 733
65. Sambrook 2006 Lancet 367 2010
66. Siris 2004 Arch Intern Med 164 1108
67. Solomon 2006 Arch Intern Med 165 2414
68. Stevenson 2005 Health Technol Assess 9 1
69. Van Staa TP, Geusens P, Zhang B et al (2007) Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids. Rheumatology (Oxford) 46:460-466
70. Watts 2004 Osteoporos Int 15 847
71. Watts 2005 J Bone Miner Res 20 2097
72. Women 2002 JAMA 288 321
73. World Health Organization (2007) Assessment of osteoporosis at the primary health care level. Summary Report of a WHO Scientific Group. WHO, Geneva
74. Zethraeus 2007 Osteoporos Int 18 9
75. Zethraeus 2008 Osteoporos Int 19 819